, a cluster of 13 cases of Campylobacter fetus intestinal and extraintestinal infections, including 2 patients with an aortic mycotic aneurysm, caused significant morbidity. The cluster likely resulted from sexual transmission between men having sex with men living in the greater Montreal area, Quebec, Canada.
METHODS
A descriptive retrospective study, approved by the ethics committee, of patients harboring a C. fetus p 31 isolate at Centre Hospitalier de l'Université de Montréal (CHUM) from March 2014 to December 2016 was performed by reviewing medical records of these patients. The Montreal Public Health Department reviewed their own prospective records of the patients, containing information about Reportable Diseases investigations. It also retrospectively contacted the affected patients by phone in order to carry out epidemiological investigation, obtained details about risk factors, sociodemographic data, comorbidities, and clinical evolution of the patients. The Laboratoire de Santé Publique du Québec identified the Campylobacter isolates to the species level with cpn60 gene sequencing. The C. fetus pulsovars were determined using pulsed-field gel electrophoresis (PFGE) with SmaI and KpnI enzymes [8, 9] . The PFGE was performed according to PulseNet Canada procedure and international standards (http://cdc. gov/pulsenet/PDF/campylobacter-pfge-protocol-598c.pdf ). Antimicrobial susceptibility testing was determined by Etest (AB Biodisk, Solna, Sweden) and the β-lactamase was determined as previously described [8, 9] . Fischer exact test was done with Epi Info software, version 6, to compare patients with bacteremia to patients with gastroenteritis. Figure 2) . The 13 C. fetus p 31, isolated from blood (n = 3) and stool (n = 10), were the only isolates of this pulsovar ever documented in the province of Quebec.
From March 2014 to December 2016, 10 men with C. fetus p 31 gastroenteritis were aged 40-69 years (median 52) and 3 men with C. fetus p 31 bacteremia were aged 56-67 years (median 60). All patients acquired their C. fetus infection in the community. These 13 men were followed in the 3 hospitals forming the CHUM and in 3 different other oupatient clinics, and they were not explicitly linked one to another. Twelve men reported to have sex with men (MSM), and 11 had high-risk sexual practices during the incubation period, such as visiting gay bathhouses or sex clubs, and using the internet to recruit sex partners. The proportion of human immunodeficiency virus (HIV)-positive patients was not different between the patients with bacteremia (1/3, 33.3%) and with gastroenteritis (7/9 for which these data were known, 77.8%) (P = .24). The 8 HIVpositive patients had CD4 cell counts from 270 to 860 (median 640) × 10 6 cells/L; 1 patient had an HIV RNA load of 2000 copies/mL, and 7 patients had HIV RNA load < 40 copies/mL. Seven of 13 patients (53.8%) were documented with 30 sexually transmitted infections (STIs) other than HIV within 3 years of their C. fetus infection: 11 Treponema pallidum, 9 Neisseria gonorrhoeae, 3 Chlamydia trachomatis, 3 Giardia lamblia, 3 Shigella species, and 1 hepatitis C infections. One patient had concomitant C. fetus and Shigella sonnei infections. Not all patients were tested for STIs during or before the cluster period. Few other risk factors were identified in these patients; no food source was documented by Montreal Public Health Department, 1 patient had the same domestic birds for years, and no patient traveled outside Quebec the week before illness onset. Of the 3 patients documented with bacteremia, 2 had an infected ruptured abdominal aortic aneurysm that required vascular surgery, and 1 had a hemorrhagic renal cyst eventually identified as renal cell carcinoma and prolonged bacteremia for 5 days. The 3 patients (100%) with bacteremia had significantly more major comorbidities (atherosclerotic vascular disease [3] , abdominal aortic aneurysm [2] , and renal neoplasia [1] ) than the 10 patients with gastroenteritis that had alcoholic cirrhosis and atherosclerotic heart disease, 1 patient each (20%) (P = .035) All 3 patients (100%) with bacteremia and 1 of 10 patients (10%) with gastroenteritis were hospitalized, for 25-46 days and for 3 days, respectively. All bacteremic patients were treated and cured with 42 days of either meropenem (1) or imipenem (2) . One patient died 3 months after cure of C. fetus bacteremia after voluntarily stopping the dialysis required from the precipitated kidney failure caused by the ruptured abdominal aortic aneurysm. Nine patients with gastroenteritis were known to have been treated with an antimicrobial agent: ciprofloxacin (5: 2 resistant and 3 susceptible isolates), azithromycin (2), and with an unknown agent (2). For these 13 patients, no relapsing C. fetus infection was documented because no further isolates of C. fetus were received in the laboratory.
All C. fetus cluster isolates were susceptible to erythromycin and tetracycline (Minimum Inhibitory Concentration (MICs) 1-2 and 0.25-0.5 mg/L, respectively). Eight isolates were resistant, and 5 were susceptible to ciprofloxacin with MICs > 32 mg/L and 0.25-0.5 mg/L, respectively. Eight C. fetus tested, isolated from blood (3) and stool (5), were susceptible to ampicillin, gentamicin, imipenem, and ertapenem (MICs 5-1, 0.5-1, 0.03-0.06, and 0 .03-0.12 mg/L, respectively) and were resistant to cefotaxime (MICs 16-32 mg/L). The isolates were β-lactamase negative.
DISCUSSION
Few C. fetus clusters have been described in the literature, even less with person-to-person transmission [2, [5] [6] [7] . As shown above, there was an increased number of patients infected with C. fetus in 2014-2016 with significantly more men than women than in 2009-2013. Thirteen men had a C. fetus infection documented from March 2014 to December 2016 forming a cluster with the same new pulsovar 31. Twelve of these patients reported to be MSM, 11 of who reported high-risk sexual practices, 8 patients were HIV positive, and 7 patients had 30 other STIs documented within 3 years of their C. fetus infection. When combining these clinical data with the 34-month duration of the cluster and the absence of documented common food source, it strongly suggests that the C. fetus infections were mainly sexually transmitted. Among MSM with high-risk sexual practices, enteric infections, often in clusters, caused by Giardia lamblia, Shigella spp., Salmonella typhi, Campylobacter spp., Helicobacter cinaedi, and Helicobacter fennelliae have been reported [8] [9] [10] [11] [12] [13] . In this population, outbreaks of sexually transmitted Shigella have been reported in many countries [10, 12] , and Salmonella typhi cluster has also been previously documented [13] . Enteric Campylobacter spp., Helicobacter cinaedi, and H. fennelliae infections suspected to be sexually transmitted in MSM and cluster isolates have been described including a case control study of Campylobacter coli outbreak and a long-lasting outbreak of erythromycin-and ciprofloxacin-resistant Campylobacter jejuni subspecies jejuni [8, 9, 11] (our unpublished data). MSM should be counseled about methods for prevention of STIs including enteric ones [8-10, 12, 13] .
Campylobacter fetus infections are associated with a significantly higher rate of bacteremia and morbidity compared with those caused by other Campylobacter species [1, 2] . The 3 patients with bacteremia had significantly more comorbidities and severe illness but had nonsignificant difference in HIV status in comparison to the 10 patients with gastroenteritis. Relapsing C. fetus infections were previously reported [2] but were not documented in the present study. Antimicrobial agents most frequently used to treat extraintestinal infections caused by C. fetus are ampicillin, gentamicin, imipenem, and meropenem [1] . Antimicrobial treatment of C. fetus gastroenteritis is unknown but may be the ones of C. jejuni/C. coli enterocolitis [1] . Clusters of multidrug-resistant Shigella and Campylobacter infections have been reported in MSM [9, 10, 12] .
There are several limitations of the present study. This study was retrospective and without a control group. The patients were not all tested for STIs. The food source investigation was not extensive and prone to a recall bias, but the epidemiological data suggested an STI in MSM. In February 2016, one C. fetus p 31 (SmaI enzyme) was untypable with KpnI enzyme. A hypothesis to explain this phenomenon is mutation of that isolate. More case control studies of Campylobacter infections in MSM should be done in the future to better characterize these infections in this population.
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